In recent years hundreds of unregulated stem cell treatment centers have cropped up across the U.S. These clinics claim to offer treatments for a wide variety of diseases and ailments by using patients’ own stem cells. These centers often use high-pressure sales tactics to prey on individuals and …
New FDA designation opens the door for stem cell trials
Dr. Temple contributed to a recent article on a stem cell clinical trial that has recently received the Food and Drug Administration's new Regenerative Medicine Advanced Therapy (RMAT) designation. Read more about how this new designation will help to promote the advancement of legitimate stem …
Dr. Messer hosts webinar for “The Scientist”
Dr. Anne Messer was one of two experts chosen to present a webinar for The Scientist (March 8, 2018.) Antibodies are the fastest growing class of synthetic therapeutics, and Dr. Messer's presentation covered their development and use as therapeutics and markers for neurodegenerative diseases. She …
Support NSCI on November 28th, #GivingTuesday
Celebrate your kindness on #GivingTuesday. On #GivingTuesday, a national day of donation, consider a gift to the Neural Stem Cell Institute. Your gift gets us closer to therapies for incurable diseases of the central nervous system including Macular Degeneration, Alzheimer's, Parkinson's, Spinal …
Unique Surgical Technique Published in Video Journal
NSCI Researchers Create Unique Surgical Technique to Aide Research in Quest for Retinal Disease Therapeutic RENSSELAER N.Y., August 30, 2017 - Age-related macular degeneration (AMD), a progressive degenerative disease of the retina, is the leading cause of blindness in the elderly. Patients with …